Accretion Nutraveda Limited Files SEBI Compliance Certificate for Q4FY26
Accretion Nutraveda Limited submitted its mandatory SEBI compliance certificate for Q4FY26, confirming all company shares remained in dematerialized form during the quarter ended 31st March, 2026. The certificate, issued by registrar KFin Technologies Limited under Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, reported no rematerialization requests during the period. This regulatory filing maintains the company's transparency obligations and demonstrates continued compliance with SEBI depositories regulations.

*this image is generated using AI for illustrative purposes only.
Accretion Nutraveda Limited has filed its quarterly compliance certificate with BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulation, 2018 for the quarter ended 31st March, 2026. The submission, dated 4th April, 2026, demonstrates the company's adherence to mandatory disclosure norms.
Regulatory Compliance Details
The certificate was issued by KFin Technologies Limited, serving as the company's Registrar and Share Transfer Agent (RTA). This document satisfies the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly reporting on dematerialization activities.
| Parameter: | Details |
|---|---|
| Reporting Period: | Quarter ended 31st March, 2026 |
| Filing Date: | 4th April, 2026 |
| Registrar: | KFin Technologies Limited |
| Regulation: | SEBI Regulation 74(5) |
| Company Status: | Formerly Accretion Nutraveda Private Limited |
Share Dematerialization Status
KFin Technologies Limited confirmed that during Q4FY26, all shares of Accretion Nutraveda Limited remained in dematerialized form. The registrar specifically noted that no rematerialization requests were received during the quarter ended 31st March, 2026.
The certificate was signed by Dnyanesh Gharote, Vice President at KFin Technologies Limited, and submitted by Company Secretary and Compliance Officer Payal Kotadiya on behalf of Accretion Nutraveda Limited.
Regulatory Framework
This filing aligns with SEBI's depositories regulations that require companies to maintain transparency regarding their share dematerialization activities. The certificate has been furnished to all stock exchanges where the company's shares are listed, ensuring comprehensive regulatory compliance across trading platforms.
What strategic initiatives might Accretion Nutraveda pursue in FY27 following its transition from private to public company status?
How could the company's 100% dematerialized share structure impact its liquidity and institutional investor appeal going forward?
Will Accretion Nutraveda consider expanding to additional stock exchanges beyond BSE to enhance market visibility?


























